Methylated RASSF1A in malignant peripheral nerve sheath tumors identifies neurofibromatosis type 1 patients with inferior prognosis
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Methylated RASSF1A in malignant peripheral nerve sheath tumors identifies neurofibromatosis type 1 patients with inferior prognosis
Authors
Keywords
-
Journal
NEURO-ONCOLOGY
Volume 17, Issue 1, Pages 63-69
Publisher
Oxford University Press (OUP)
Online
2014-07-20
DOI
10.1093/neuonc/nou140
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis
- (2013) Eric P Rahrmann et al. NATURE GENETICS
- Microarray-based copy number analysis of neurofibromatosis type-1 (NF1)-associated malignant peripheral nerve sheath tumors reveals a role for Rho-GTPase pathway genes in NF1 tumorigenesis
- (2012) Meena Upadhyaya et al. HUMAN MUTATION
- Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1
- (2012) M. Kolberg et al. NEURO-ONCOLOGY
- Impaired Pten Expression in Human Malignant Peripheral Nerve Sheath Tumours
- (2012) Maren Bradtmöller et al. PLoS One
- Molecular mechanisms promoting the pathogenesis of Schwann cell neoplasms
- (2011) Steven L. Carroll ACTA NEUROPATHOLOGICA
- Prognostic Significance of p14ARF, p15INK4b, and p16INK4a Inactivation in Malignant Peripheral Nerve Sheath Tumors
- (2011) M. Endo et al. CLINICAL CANCER RESEARCH
- Activated MET Is a Molecular Prognosticator and Potential Therapeutic Target for Malignant Peripheral Nerve Sheath Tumors
- (2011) K. E. Torres et al. CLINICAL CANCER RESEARCH
- Comparative methylome analysis of benign and malignant peripheral nerve sheath tumors
- (2011) A. Feber et al. GENOME RESEARCH
- SPG20, a novel biomarker for early detection of colorectal cancer, encodes a regulator of cytokinesis
- (2011) G E Lind et al. ONCOGENE
- High RASSF1A promoter methylation levels are predictive of poor prognosis in fine-needle aspirate washings of breast cancer lesions
- (2010) Ana Teresa Martins et al. BREAST CANCER RESEARCH AND TREATMENT
- The prognostic value of RASSF1A promoter hypermethylation in non-small cell lung carcinoma: a systematic review and meta-analysis
- (2010) Jun Wang et al. CARCINOGENESIS
- Genomic Changes in Chromosomes 10, 16, and X in Malignant Peripheral Nerve Sheath Tumors Identify a High-Risk Patient Group
- (2010) Helge R. Brekke et al. JOURNAL OF CLINICAL ONCOLOGY
- Methylation level of the RASSF1A promoter is an independent prognostic factor for clear-cell renal cell carcinoma
- (2009) Y. Kawai et al. ANNALS OF ONCOLOGY
- Clinical, Pathological, and Molecular Variables Predictive of Malignant Peripheral Nerve Sheath Tumor Outcome
- (2009) Changye Zou et al. ANNALS OF SURGERY
- Identification of p53 as a strong predictor of survival for patients with malignant peripheral nerve sheath tumors
- (2009) Helge R. Brekke et al. NEURO-ONCOLOGY
- PDGFRA, PDGFRB, EGFR, and downstream signaling activation in malignant peripheral nerve sheath tumor
- (2009) Federica Perrone et al. NEURO-ONCOLOGY
- The methylation status ofRASSF1Apromoter predicts responsiveness to chemotherapy and eventual cure in hepatoblastoma patients
- (2008) Shohei Honda et al. INTERNATIONAL JOURNAL OF CANCER
- Germline and somaticNF1mutations in sporadic and NF1-associated malignant peripheral nerve sheath tumours
- (2008) Irene Bottillo et al. JOURNAL OF PATHOLOGY
- EGFR and erbB2 in malignant peripheral nerve sheath tumors and implications for targeted therapy
- (2008) Nikola Holtkamp et al. NEURO-ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started